APOE and frontotemporal dementia: Studies have linked APOE ε4 to increased risk and lower age of onset of frontotemporal dementia (FTD)2–6, Parkinson’s disease (PD)5,7,8 and amyotrophic lateral sclerosis (ALS)9,10.